US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 10.620
  • -0.060-0.56%
Close Dec 13 16:00 ET
  • 10.620
  • 0.0000.00%
Post 16:00 ET
257.95MMarket Cap-4.21P/E (TTM)

Artiva Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-8.03%-11.61M
-16.33%-13.69M
-5.92%-15.09M
6.69%-47.43M
-10.68M
-10.75M
-11.76M
-47.38%-14.24M
-232.13%-50.83M
-213.96%-9.66M
Net income from continuing operations
-254.91%-17.47M
-58.13%-17.84M
16.47%-13.96M
51.15%-28.72M
---12M
--11.28M
---11.28M
-37.88%-16.72M
18.15%-58.79M
71.62%-12.12M
Operating gains losses
--977K
--2.35M
--268K
--707K
----
----
----
----
----
----
Depreciation and amortization
12.77%627K
12.08%603K
1.56%587K
95.68%2.27M
--594K
--556K
--538K
246.11%578K
366.94%1.16M
421.88%167K
Change In working capital
112.65%3.01M
99.80%-7K
-4,812.50%-3.02M
-631.51%-28.28M
---1.09M
---23.8M
---3.46M
-93.11%64K
-111.57%-3.87M
-97.11%929K
-Change in receivables
231.26%760K
116.91%262K
104.26%35K
-2,064.91%-1.23M
--1.72M
---579K
---1.55M
-9.89%-822K
87.82%-57K
-1,285.19%-748K
-Change in prepaid assets
-94.43%-1.5M
-77.39%296K
-291.63%-936K
167.54%516K
--218K
---772K
--1.31M
72.14%-239K
-232.17%-764K
-167.29%-858K
-Change in payables and accrued expense
210.19%3.81M
53.74%-681K
-411.22%-2.19M
-114.63%-1.32M
---1.78M
--1.23M
---1.47M
-77.83%704K
-111.85%-615K
22.96%3.18M
-Change in other current assets
3.23%32K
3.33%31K
-6.06%31K
214.88%139K
--45K
--31K
--30K
--33K
---121K
----
-Change in other current liabilities
----
----
----
--0
----
----
----
----
--74K
----
-Change in other working capital
99.63%-88K
104.78%85K
-88.40%45K
-1,007.05%-26.38M
---1.29M
---23.7M
---1.78M
160.53%388K
-108.24%-2.38M
-102.14%-641K
Cash from discontinued investing activities
Operating cash flow
-8.03%-11.61M
-16.33%-13.69M
-5.92%-15.09M
6.69%-47.43M
---10.68M
---10.75M
---11.76M
-47.38%-14.24M
-232.13%-50.83M
-213.96%-9.66M
Investing cash flow
Cash flow from continuing investing activities
-26,396.55%-130.63M
106.44%1.35M
625.35%9.78M
-312.37%-25.98M
-2.67M
-493K
-20.95M
-209.30%-1.86M
-265.37%-6.3M
-1,208.70%-602K
Net PPE purchase and sale
46.37%-96K
20.14%-464K
99.03%-18K
48.28%-3.26M
---636K
---179K
---581K
-209.30%-1.86M
-265.37%-6.3M
-1,208.70%-602K
Net investment purchase and sale
-41,470.70%-130.53M
108.90%1.81M
--9.8M
---22.72M
---2.03M
---314K
---20.37M
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
-26,396.55%-130.63M
106.44%1.35M
625.35%9.78M
-312.37%-25.98M
---2.67M
---493K
---20.95M
-209.30%-1.86M
-265.37%-6.3M
-1,208.70%-602K
Financing cash flow
Cash flow from continuing financing activities
599.38%163.87M
-16,260.00%-1.62M
0
2,029.67%24.39M
962K
23.43M
10K
96.07%-12K
-100.83%-1.26M
-100.20%-305K
Net issuance payments of debt
---38K
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--166.51M
--0
--0
-140.00%-12K
--0
--0
--0
---12K
---5K
----
Net preferred stock issuance
----
----
----
----
----
----
----
----
----
--0
Proceeds from stock option exercised by employees
--6K
----
----
7,250.30%24.4M
--24.39M
--0
----
----
89.71%332K
47.41%199K
Net other financing activities
---2.6M
----
----
----
----
----
----
----
21.74%-1.59M
34.63%-504K
Cash from discontinued financing activities
Financing cash flow
599.38%163.87M
-16,260.00%-1.62M
--0
2,029.67%24.39M
--962K
--23.43M
--10K
96.07%-12K
-100.83%-1.26M
-100.20%-305K
Net cash flow
Beginning cash position
-36.04%34.51M
-44.08%48.46M
-47.69%53.76M
-36.23%102.78M
--66.14M
--53.95M
--86.66M
-36.23%102.78M
533.47%161.17M
533.47%161.17M
Current changes in cash
77.47%21.63M
57.34%-13.95M
67.09%-5.3M
16.06%-49.01M
---12.38M
--12.19M
---32.71M
-52.46%-16.12M
-143.02%-58.39M
-106.51%-10.57M
End cash Position
-15.12%56.14M
-36.04%34.51M
-44.08%48.46M
-47.69%53.76M
--53.76M
--66.14M
--53.95M
-42.46%86.66M
-36.23%102.78M
-19.83%150.6M
Free cash flow
-7.14%-11.71M
-14.61%-14.15M
6.22%-15.1M
11.27%-50.69M
---11.31M
---10.93M
---12.35M
-56.88%-16.11M
-235.49%-57.13M
-221.72%-10.27M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -8.03%-11.61M-16.33%-13.69M-5.92%-15.09M6.69%-47.43M-10.68M-10.75M-11.76M-47.38%-14.24M-232.13%-50.83M-213.96%-9.66M
Net income from continuing operations -254.91%-17.47M-58.13%-17.84M16.47%-13.96M51.15%-28.72M---12M--11.28M---11.28M-37.88%-16.72M18.15%-58.79M71.62%-12.12M
Operating gains losses --977K--2.35M--268K--707K------------------------
Depreciation and amortization 12.77%627K12.08%603K1.56%587K95.68%2.27M--594K--556K--538K246.11%578K366.94%1.16M421.88%167K
Change In working capital 112.65%3.01M99.80%-7K-4,812.50%-3.02M-631.51%-28.28M---1.09M---23.8M---3.46M-93.11%64K-111.57%-3.87M-97.11%929K
-Change in receivables 231.26%760K116.91%262K104.26%35K-2,064.91%-1.23M--1.72M---579K---1.55M-9.89%-822K87.82%-57K-1,285.19%-748K
-Change in prepaid assets -94.43%-1.5M-77.39%296K-291.63%-936K167.54%516K--218K---772K--1.31M72.14%-239K-232.17%-764K-167.29%-858K
-Change in payables and accrued expense 210.19%3.81M53.74%-681K-411.22%-2.19M-114.63%-1.32M---1.78M--1.23M---1.47M-77.83%704K-111.85%-615K22.96%3.18M
-Change in other current assets 3.23%32K3.33%31K-6.06%31K214.88%139K--45K--31K--30K--33K---121K----
-Change in other current liabilities --------------0------------------74K----
-Change in other working capital 99.63%-88K104.78%85K-88.40%45K-1,007.05%-26.38M---1.29M---23.7M---1.78M160.53%388K-108.24%-2.38M-102.14%-641K
Cash from discontinued investing activities
Operating cash flow -8.03%-11.61M-16.33%-13.69M-5.92%-15.09M6.69%-47.43M---10.68M---10.75M---11.76M-47.38%-14.24M-232.13%-50.83M-213.96%-9.66M
Investing cash flow
Cash flow from continuing investing activities -26,396.55%-130.63M106.44%1.35M625.35%9.78M-312.37%-25.98M-2.67M-493K-20.95M-209.30%-1.86M-265.37%-6.3M-1,208.70%-602K
Net PPE purchase and sale 46.37%-96K20.14%-464K99.03%-18K48.28%-3.26M---636K---179K---581K-209.30%-1.86M-265.37%-6.3M-1,208.70%-602K
Net investment purchase and sale -41,470.70%-130.53M108.90%1.81M--9.8M---22.72M---2.03M---314K---20.37M--0--0----
Cash from discontinued investing activities
Investing cash flow -26,396.55%-130.63M106.44%1.35M625.35%9.78M-312.37%-25.98M---2.67M---493K---20.95M-209.30%-1.86M-265.37%-6.3M-1,208.70%-602K
Financing cash flow
Cash flow from continuing financing activities 599.38%163.87M-16,260.00%-1.62M02,029.67%24.39M962K23.43M10K96.07%-12K-100.83%-1.26M-100.20%-305K
Net issuance payments of debt ---38K------------------0----------------
Net common stock issuance --166.51M--0--0-140.00%-12K--0--0--0---12K---5K----
Net preferred stock issuance --------------------------------------0
Proceeds from stock option exercised by employees --6K--------7,250.30%24.4M--24.39M--0--------89.71%332K47.41%199K
Net other financing activities ---2.6M----------------------------21.74%-1.59M34.63%-504K
Cash from discontinued financing activities
Financing cash flow 599.38%163.87M-16,260.00%-1.62M--02,029.67%24.39M--962K--23.43M--10K96.07%-12K-100.83%-1.26M-100.20%-305K
Net cash flow
Beginning cash position -36.04%34.51M-44.08%48.46M-47.69%53.76M-36.23%102.78M--66.14M--53.95M--86.66M-36.23%102.78M533.47%161.17M533.47%161.17M
Current changes in cash 77.47%21.63M57.34%-13.95M67.09%-5.3M16.06%-49.01M---12.38M--12.19M---32.71M-52.46%-16.12M-143.02%-58.39M-106.51%-10.57M
End cash Position -15.12%56.14M-36.04%34.51M-44.08%48.46M-47.69%53.76M--53.76M--66.14M--53.95M-42.46%86.66M-36.23%102.78M-19.83%150.6M
Free cash flow -7.14%-11.71M-14.61%-14.15M6.22%-15.1M11.27%-50.69M---11.31M---10.93M---12.35M-56.88%-16.11M-235.49%-57.13M-221.72%-10.27M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List

Investment Theme Recent IPOs
Recent IPOs
Intraday-0.76%